High materiality7/10
Jazz Pharmaceuticals (JAZZ) PT Raised to $277 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target $277; price $257.54; RBC Capital.
- RBC Capital raises JAZZ target to $277; price $257.54.
Key facts
- 01
Target: $277
- 02
Posted price: $257.54
- 03
Analyst firm: RBC Capital
- 04
Analyst: Leonid Timashev
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.